Greenwood Capital Associates LLC Catalent, Inc. Transaction History

Greenwood Capital Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$72.36 - $113.1 $774,252 - $1.21 Million	-10,700 Reduced 17.06%	52,027 $3.77 Million
Q2 2022 Aug 10, 2022	SELL	$87.2 - $114.05 $1.09 Million - $1.42 Million	-12,471 Reduced 16.58%	62,727 $6.73 Million
Q1 2022 May 10, 2022	BUY	$94.19 - $124.49 $1.21 Million - $1.6 Million	12,852 Added 20.61%	75,198 $8.34 Million
Q4 2021 Feb 03, 2022	BUY	$119.57 - $139.07 $893,187 - $1.04 Million	7,470 Added 13.61%	62,346 $7.98 Million
Q3 2021 Oct 27, 2021	SELL	$109.17 - $142.35 $72,379 - $94,378	-663 Reduced 1.19%	54,876 $7.3 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $1.75 Million - $2.02 Million	17,473 Added 45.9%	55,539 $6.01 Million
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $365,436 - $450,972	3,600 Added 10.45%	38,066 $4.01 Million
Q4 2020 Feb 09, 2021	BUY	$85.88 - $105.36 $2.96 Million - $3.63 Million	34,466 New	34,466 $3.59 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Greenwood Capital Associates LLC with notifications on news.